[Corrigendum] MicroRNA-1258: An invasion and metastasis regulator that targets heparanase in gastric cancer

• Authors:
  • Jinxin Shi
  • Ping Chen
  • Jingxu Sun
  • Yongxi Song
  • Bin Ma
  • Peng Gao
  • Xiaowan Chen
  • Zhenning Wang

• View Affiliations

  
  Affiliations: Department of Surgical Oncology and General Surgery, First Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China
• Published online on: October 20, 2021     https://doi.org/10.3892/ol.2021.13103
• Article Number: 842

• Copyright : © Shi et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Article

Oncol Lett 13: [Related article:] 3739-3745, 2017; DOI: 10.3892/ol.2017.5886

Subsequently to the publication of the above article, the authors have realized that the labels for Figure parts 1B and 1C were printed the wrong way around; furthermore, a pair of the data panels were inadvertently featured in Fig. 2 containing overlapping data which were derived from the same original source, even though the data were intended to have represented different experimental conditions.

Figure 2. Overexpression of miR-1258 suppresses SGC-7901 cell invasion in vitro. A Transwell invasion assay was performed to estimate the effect of miR-1258 on the invasive potential of gastric cancer cells. (A) Representative images and (B) quantification of the cells that had migrated to the basal side of the membrane. Magnification, ×200. **P<0.01, miR-1258 transfected vs. untransfected SGC-7901 cells. miR-1258, microRNA-1258; NC, negative control.

A correctly labelled version of Fig. 1 is shown below, and the corrected version of Fig. 2 is shown on the next page, featuring the correct data for the SGC-7901 experiment. Note that the errors in the Figure did not affect either the results or the conclusions reported in this study. The authors are grateful to the Editor of Oncology Letters for granting them the opportunity to publish this corrigendum, and regret any inconvenience caused to the readership of the Journal.

Figure 1. Expression of miR-1258 in tissues and cell lines. (A) miR-1258 was detected in 116 patients with gastric cancer using the reverse transcription-quantitative polymerase chain reaction. Results are presented as log2 fold change of gastric cancer relative to NATs. (B) Significantly increased ΔCq values for miR-1258 were observed between gastric cancer tissues and NATs. (C) Mean expression of miR-1258 in gastric cancer cell lines (MGC-803, SGC-7901 and BGC-823) relative to NATs. (D) MTT proliferation assay in SGC-7901 cells. *P<0.05; **P<0.01 vs. NAT. miR-1258, microRNA-1258; NAT, non-tumor adjacent tissue; NC, negative control.